Special Purpose Acquisition Companies: The Briscoe Law Firm, PLLC Announce Investigation into the following SPACs

3/8/23 5:30:00 PM ET

$BBAI

$BOXD

$SNTI

$TNGX

Computer Software: Prepackaged Software

Technology

Diversified Commercial Services

Miscellaneous

Get the next $BBAI alert in real time by email

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm The Briscoe Law Firm, PLLC are investigating potential violation of laws in connection with the following special purpose acquisition companies ("SPACs"): BigBear.ai Holdings, Inc. f/k/a GigCapital4 Inc. (NYSE:BBAI), Senti Biosciences, Inc. f/k/a Dynamics Special Purpose Corp (NASDAQGM:SNTI), Tango Therapeutics, Inc. f/k/a BCTG Acquisition Corp (NASDAQGM:TNGX), and Boxed, Inc. f/k/a Seven Oaks Acquisition Corp (NYSE:BOXD).

If you are an affected investor, and you want to learn more about this investigation, please contact Willie Briscoe at The Briscoe Law Firm, PLLC, (972) 521-6868, or via email at [email protected]. There is no cost or fee to you.

The Briscoe Law Firm, PLLC is a full service business litigation and shareholder rights advocacy firm with more than 23 years of experience in complex securities litigation and transactional matters.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230308005867/en/

Get the next $BBAI alert in real time by email

Recent Analyst Ratings for

Company	Date	Price Target	Rating	Analyst
Tango Therapeutics Inc. $TNGX	7/17/2024	$19.00	Buy	Jefferies
Tango Therapeutics Inc. $TNGX	4/4/2024		Overweight	Cantor Fitzgerald
Tango Therapeutics Inc. $TNGX	2/12/2024	$18.00	Overweight	Piper Sandler
BigBear.ai Inc. $BBAI	1/9/2024	$3.00	Overweight	Cantor Fitzgerald
Tango Therapeutics Inc. $TNGX	12/8/2023	$16.00	Buy	B. Riley Securities
BigBear.ai Inc. $BBAI	10/2/2023	$2.00	Market Perform	TD Cowen
BigBear.ai Inc. $BBAI	8/29/2023	$4.00	Buy	H.C. Wainwright
Tango Therapeutics Inc. $TNGX	10/20/2022	$10.00	Neutral → Buy	H.C. Wainwright

More analyst ratings

Special Purpose Acquisition Companies: The Briscoe Law Firm, PLLC Announce Investigation into the following SPACs

Chat with this insight

Recent Analyst Ratings for $BBAI$BOXD$SNTI$TNGX

$BBAI$BOXD$SNTI$TNGX Financials

Live finance-specific insights

Senti Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights

BigBear.ai to Report Third Quarter 2024 Results on November 5, 2024

Senti Bio to Participate in Upcoming Investor Conferences

$BBAI$BOXD$SNTI$TNGX Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Rothenberg Mace bought $74,000 worth of shares (20,000 units at $3.70), increasing direct ownership by 178% to 31,250 units (SEC Form 4)

Braden Pamela Joyce bought $209,999 worth of shares (140,939 units at $1.49), increasing direct ownership by 46% to 446,396 units (SEC Form 4)

Braden Pamela Joyce bought $96,048 worth of shares (50,025 units at $1.92), increasing direct ownership by 20% to 305,457 units (SEC Form 4)

$BBAI$BOXD$SNTI$TNGX Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Jefferies initiated coverage on Tango Therapeutics with a new price target

Cantor Fitzgerald initiated coverage on Tango Therapeutics

Piper Sandler initiated coverage on Tango Therapeutics with a new price target

$BBAI$BOXD$SNTI$TNGX SEC Filings

SEC Form 10-Q filed by Senti Biosciences Inc.

Senti Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

SEC Form 10-Q filed by BigBear.ai Inc.

$BBAI$BOXD$SNTI$TNGX Press Releases

Fastest customizable press release news feed in the world

Senti Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights

Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program

$BBAI$BOXD$SNTI$TNGX Leadership Updates

Live Leadership Updates

BigBear.ai Names Carl Napoletano as Chief Operating Officer

Tango Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Highlights

Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer

$BBAI$BOXD$SNTI$TNGX Market Insights

Live Market Insights

Shares of companies within the broader technology sector are trading lower amid a selloff in chips and AI-related stocks.

Jefferies Initiates Coverage On Tango Therapeutics with Buy Rating, Announces Price Target of $19

Senti Bio Announces 1-for-10 Reverse Stock Split, Effective Jun. 17

$BBAI$BOXD$SNTI$TNGX Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by Tango Therapeutics Inc.

Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

Amendment: SEC Form SC 13D/A filed by Tango Therapeutics Inc.

$BBAI$BOXD$SNTI$TNGX Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Bbai Ultimate Holdings, Llc sold $1,798,894 worth of shares (893,315 units at $2.01) (SEC Form 4)

Director Bbai Ultimate Holdings, Llc sold $707,937 worth of shares (395,623 units at $1.79) (SEC Form 4)

Director Rothenberg Mace bought $74,000 worth of shares (20,000 units at $3.70), increasing direct ownership by 178% to 31,250 units (SEC Form 4)

Recent Analyst Ratings for
$BBAI
$BOXD
$SNTI
$TNGX

$BBAI
$BOXD
$SNTI
$TNGX
Financials

$BBAI
$BOXD
$SNTI
$TNGX
Insider Purchases

$BBAI
$BOXD
$SNTI
$TNGX
Analyst Ratings

$BBAI
$BOXD
$SNTI
$TNGX
SEC Filings

$BBAI
$BOXD
$SNTI
$TNGX
Press Releases

$BBAI
$BOXD
$SNTI
$TNGX
Leadership Updates

$BBAI
$BOXD
$SNTI
$TNGX
Market Insights

$BBAI
$BOXD
$SNTI
$TNGX
Large Ownership Changes

$BBAI
$BOXD
$SNTI
$TNGX
Insider Trading